FindMyKOL
Clinical trialNCT00693121CompletedPhase 4Interventional

Amantadine for Treatment of Symptoms of the Post-traumatic Confusional State

SponsorMethodist Rehabilitation CenterEnrollment79DeliriumPosttraumatic Confusional StateTraumatic Brain Injury
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Patients with traumatic brain injury often experience a period of acute confusion that may include agitation as they recover from their injuries. While this confusion generally resolves with time, patients may pose increased risk of injury to themselves or others during this period. Their behavior may also increase stress for family members and interfere with their ability to benefit from rehabilitation therapies. A number of different medications have been used to treat confusion to decrease agitation, decrease risk of injury, and improve participation in rehabilitation therapies. To this point, there has not been a research or scientific basis for knowing which medication is the best for a specific patient. The overall goal of this study is to conduct a scientific investigation to help determine which medication works best to treat confusion. Study hypothesis: Amantadine will reduce the severity and number of symptoms of acute confusion after traumatic brain injury.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • Mark Sherer, Ph.D.

    Department of Research, Memorial Hermann/TIRR, Houston, TX

    Study Director
  • Risa N Richardson, Ph.D.

    Polytrauma Program, James A. Haley Veterans Hospital, Tampa, FL

    Study Director
  • Stuart A Yablon, M.D.

    Brain Injury Program, Methodist Rehabilitation Center

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Methodist Rehabilitation Center

    Jackson, Mississippi, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2003
Primary completion
30 Nov 2007
Completion
31 Mar 2019
Last update posted
18 Oct 2023
Registered enrollment
79
Registry id
NCT00693121

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.